Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Oct 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4651609012 | Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4651610019 | Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | Conventional release cutaneous cream | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Metronidazole | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance | Metronidazole | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Sucralfate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance | Sucralfate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR